This study applied a Case‑Case genome‑wide association study (CC‑GWAS) to identify common variants that differentially associate with schizophrenia versus bipolar disorder. The analysis compared 67,390 schizophrenia cases with 41,917 bipolar disorder cases to detect alleles that show opposing directions of effect between the two diagnostic categories. The authors note that schizophrenia and bipolar disorder are diagnostically distinct but share substantial clinical and genetic overlap; the CC‑GWAS approach aims to reveal variants that contribute specifically to liability for one disorder compared with the other.
The CC‑GWAS identified 19 genome‑wide significant loci. Of these, 16 loci (84%) demonstrated divergent genetic effects, meaning the same risk allele was associated with increased risk for one disorder and decreased risk for the other. This pattern indicates that beyond shared genetic liability, there are common variants with opposite-direction associations that may contribute to biological differences between schizophrenia and bipolar disorder.
Summary statistics from the CC‑GWAS showed detectable disorder‑differentiating heritability estimated at 10.27% (SE = 0.01). The CC‑GWAS results produced genetic correlations indicating that alleles differentiating toward schizophrenia were associated with several external phenotypes: lower educational attainment, lower cognitive performance, and increased risk for attention‑deficit/hyperactivity disorder (ADHD), anorexia, autism, bipolar disorder type 1 (BD1) but not bipolar disorder type 2 (BD2), cannabis use disorder, and obsessive‑compulsive disorder (OCD). These correlations suggest that schizophrenia‑differentiating variants mark neurodevelopmental and cognitive dimensions that differ from those marked by bipolar‑differentiating variants.
Four of the 19 loci showed divergent effects despite not reaching genome‑wide significance in either individual disorder GWAS. This result demonstrates the enhanced power of a direct case‑case comparison to detect variants with opposite effects that may be missed when analysing each disorder separately against controls.
Functional annotation of the CC‑GWAS loci mapped 102 genes. These mapped genes were significantly enriched for expression across all 13 brain regions tested and showed no significant enrichment in peripheral tissues. The brain‑wide enrichment supports a central nervous system locus for the disorder‑differentiating genetic signal identified by CC‑GWAS.
Gene set enrichment analysis implicated neuronal projection and synaptic compartments as the strongest biological themes differentiating schizophrenia and bipolar disorder. These compartmental enrichments suggest that differences in neuronal connectivity, projection development, or synaptic function may underlie some of the divergent genetic architecture between the disorders.
Polygenic risk scores (PRS) derived from the disorder‑differentiating variants were associated with clinical features in schizophrenia: specifically, higher PRS from these variants correlated with earlier age at onset and more severe negative symptoms. The authors interpret these associations as consistent with the disorder‑differentiating variants marking neurodevelopmental dimensions of illness severity within schizophrenia.
The study provides specific genomic targets for understanding pathogenic differences between schizophrenia and bipolar disorder and demonstrates that genuine divergent common‑variant effects exist in addition to substantial shared liability. By identifying loci with opposite‑direction effects and brain‑enriched mapped genes, the results point to neuronal projection and synaptic biology as candidate pathways for further functional follow‑up.
Limitations explicitly noted by the source: this report is a preprint that has not been certified by peer review. As such, the findings represent new medical research that has not yet undergone formal peer evaluation and should not be used to guide clinical practice. The source does not report additional methodological details beyond the sample sizes, number of loci, mapped genes, heritability estimate, and the listed phenotypic correlations.
Overall, the CC‑GWAS approach in this dataset identified multiple loci with divergent effects between schizophrenia and bipolar disorder, mapped a set of brain‑expressed genes, implicated synaptic and neuronal projection biology, and linked disorder‑differentiating polygenic risk to earlier onset and more severe negative symptoms in schizophrenia. These findings provide hypotheses and targets for subsequent replication, functional studies, and mechanistic investigation.